Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abnova™ Human lg-kappa CISH Probe

Human lg-kappa CISH Probe is designed for the qualitative detection of human Ig-kappa light chain mRNA in formalin-fixed, paraffin-embedded specimens by chromogenic in situ hybridization (CISH).

Supplier:  Abnova™ CG0030

Catalog No. 89-335-581


Only null left
Add to Cart

Description

Description

The probe is intended to be used in combination with the CISH Implementation HRP-DAB Kit, which provides necessary reagents for specimen pretreatment and post-hybridization processing.

A positive reactivity in plasma B-cells is indicated by cytoplasmic staining. In lymphoid tissue, the normal kappa-to-lambda ratio is roughly 2:1, an indication for monoclonality is given if the kappa-to-lambda ratio is greater than 3:1 or less than 0.3:1. Visualization of signals should be performed at least at 100-fold magnification resulting in easily visible signals. Do not evaluate areas of necrosis, overlapping nuclei, over-digested nuclei, and nuclei with weak signal intensity.
Specifications

Specifications

CISH-P
Reagent Provided:

Digoxigenin-labeled oligonucleotides targeting mRNA sequences encoding Ig-kappa light chain constant regions.
Ready-to-use. No reconstitution, mixing, or dilution required. Bring to room temperature and mix briefly before use. Typically used with Human Ig-lambda CISH Probe
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.